civil society
By
civil society
Published: Feb. 25, 2021, 7:48 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
Advocates demand Cepheid commit a greater proportion of its COVID-19 manufacturing capacity to LMICs and lower the price of its cartridges to $5.
Read More →
By
TB activists,
civil society
Published: Feb. 18, 2021, 8:36 p.m.·
Tags:
TB programs,
Prevention,
HIV coinfection,
Access,
Advocacy
Indian activists demand the introduction of the newer short-course TB preventive treatment regimens for people living with HIV.
Read More →
By
civil society
Published: Sept. 2, 2020, 4:44 p.m.·
Tags:
Global TB response,
Advocacy
The results of the global civil-society led survey about the impact of COVID-19 on the TB epidemic will be virtually launched on 15 September 2020.
Read More →
By
civil society
Published: May 28, 2020, 11:32 p.m.·
Tags:
Advocacy
You are invited to participate in a civil society-led survey on the impact of COVID-19 on TB programs and services around the world.
Read More →
By
civil society
Published: Oct. 31, 2019, 10:10 a.m.·
Tags:
Prevention,
Access,
Advocacy
A lower price for rifapentine is just a start — communities need more than discounts to access TB preventive therapy!
Read More →
By
civil society
Published: Oct. 30, 2019, 3:57 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Research and development,
Access,
Advocacy
Civil society activists storm the stage at The Union Conference to demand affordability, transparency and accountability from the TB Alliance.
Read More →
By
civil society
Published: Sept. 24, 2018, 11:19 a.m.·
Tags:
Global TB response,
Advocacy
Joint statement on behalf of affected communities and civil society on the occasion of the first United Nations High-Level Meeting on the Fight to End Tuberculosis; Deadline for sign-on: 12:00 pm New York time, 25 September.
Read More →
By
civil society
Published: Sept. 24, 2018, 11:05 a.m.·
Tags:
Global TB response,
Advocacy
Statement from civil society and affected communities in response to the World Health Organization (WHO)'s Global TB Report 2018.
Read More →
By
civil society
Published: Aug. 29, 2018, 6:21 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Prevention,
Pediatrics,
Access,
Advocacy
Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.
Read More →
By
civil society,
TB advocates
Published: July 13, 2018, 10:02 a.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Advocates request that bedaquiline become part of the standard treatment regimen for drug-resistant TB in India.
Read More →
Page 1 of 4 · Total posts: 10
1
2
Last→